Tekmira to Present at RBC Capital Markets' Healthcare Conference
February 12 2015 - 5:00PM
Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a
leading developer of RNA interference (RNAi) therapeutics, today
announced that Dr. Mark J. Murray, Tekmira's President and CEO,
will present a company overview at the 2015 RBC Capital Markets'
Healthcare Conference on Tuesday, February 24, 2015 at 12:05 –
12:30 pm (PT) / 3:05 pm – 3:30 pm (ET) at The New York Palace Hotel
in New York.
Webcast Information
A live webcast of the corporate overview presentation can be
accessed through the Investor Section of Tekmira's website at
www.tekmira.com. The webcast will be available approximately 90
minutes after the event has taken place.
About Tekmira
Tekmira Pharmaceuticals Corporation is a biopharmaceutical
company focused on advancing novel RNAi therapeutics and providing
its leading lipid nanoparticle (LNP) delivery technology to
pharmaceutical and biotechnology partners. Tekmira has been working
in the field of nucleic acid delivery for over a decade, and has
broad intellectual property covering its delivery technology.
Further information about Tekmira can be found at www.tekmira.com.
Tekmira is based in Vancouver, Canada and Seattle, USA.
CONTACT: Investors
Julie P. Rezler
Director, Investor Relations
Phone: 604-419-3200
Email: jrezler@tekmira.com
Media
Please direct all media inquiries to media@tekmira.com
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Sep 2023 to Sep 2024